newsfilter
← Latest News
GlobeNewswire·

Idera Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2019 Financial Results

EXTON, Pa., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA), a clinical-stage biopharmaceutical company focused on the development, and ultimately the...